Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Shield Therapeutics Plc LSE:STX London Ordinary Share GB00BYV81293 ORD 1.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -2.50 -2.78% 87.50 85.00 90.00 90.00 87.50 90.00 15,829 16:11:26
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.7 -9.1 -8.0 - 103

Shield Therapeutics Share Discussion Threads

Showing 5626 to 5649 of 6225 messages
Chat Pages: Latest  237  236  235  234  233  232  231  230  229  228  227  226  Older
DateSubjectAuthorDiscuss
22/4/2020
08:10
Why will it not replace Cranky ?
peachie 74
22/4/2020
08:03
The finance guy is in there to salvage the situation in my view. They need to close the US deal QUICKLY. My guess is that the major shareholders have lost patience with Carl and his strategy which as we have been told ad nauseum is to focus on hospital prescribing. It's an oral iron. It's a great oral iron. It's not going to replace IV iron.
crankyman
22/4/2020
07:57
https://www.bloomberg.com/profile/person/6888336 Good looking CV
peachie 74
22/4/2020
07:52
Perhaps a few in the know got wind of this days ago, hence the rise on increased vols. Should be viewed as a positive imo
ny boy
22/4/2020
07:50
Perhaps major shareholders not happy how quick US deal executed ? Just guessing !?! Anyway. Let’s hope the steady rise continues. We have an amazing product here let’s not forget
peachie 74
22/4/2020
07:42
Very intriguing. I too cannot see it as a positive but we will see; the proof is in the eating of the licensing deal (bit of a mixed metaphor). One silver lining is that the costs will be lower because presumably Carl will be off the payroll....
nobbygnome
22/4/2020
07:42
peachie, now now....hehe
qs99
22/4/2020
07:41
“After discussions with the board and major shareholders” does suggest he was encouraged out maybe ? Otherwise why involve major shareholders. He would just be telling them he is leaving ? No major share holders have dumped on back of what they knew was coming btw
peachie 74
22/4/2020
07:38
Non taken best. As holders let’s hope the deal in the US is a real good one eh ! Perhaps he was nobbling the cleaner !
peachie 74
22/4/2020
07:36
I didn’t comment that the Products success was down to one Man although he founded the company I was just slightly frustrated that your Posts put a slightly positive spin on the News nothing else and I will leave it at that No offensive intended
best1467
22/4/2020
07:32
well the messaging will go on behind the scenes and talks of being in conjunction with the shareholders no, so maybe city have forced him out?
qs99
22/4/2020
07:30
I did not say it’s not a negative. Seeing Carl’s presentations and knowing what he’s done for the company, etc would make you want him to stay But the products success is not wholly down to one man. I don’t have my head in the sand , esp the spring !
peachie 74
22/4/2020
07:20
This help US deal happen sooner rather than later too. He wouldn’t carry on if it was ages away.
peachie 74
22/4/2020
07:19
The world and people move on for a whole host of personal or professional reasons. No reflection on the product. US deal still happening. If it was dead in the water he would not carry on helping it over the line, that’s one good thing. And if it was even a poor deal he wouldn’t hang on as to tarnish his reputation. Who knows his reasons , wife might be ill, etc. No real point speculating. Main thing is him carrying on pushing US deal through and confidence in Feraccru. If it was for anything negative regards company or product it would have to be declared. On wards and upwards. We still have a proven derisked product FDA broad label approved to compete with IV administration for the worlds biggest deficiency. GLA
peachie 74
22/4/2020
07:16
Because they need a big biz guy to close the deal with US. Watts has the right cv Tim Watts has been appointed as Chief Executive Officer from his role as Chief Financial Officer (CFO), which he has occupied since August 2018 and will be appointed to the Board in due course. Tim has extensive biotech and Pharmaceutical experience, having previously been CFO of Oxford BioMedica PLC and Archimedes Pharma Ltd, preceded by 22 years at AstraZeneca. His knowledge of the Company and his strong biopharmaceutical background will be critical to further advancing the business." Sounds like a deal is close, they mention it twice Recognising the value to Shield and its shareholders of successfully completing the ongoing US partnering activities for Feraccru(R)/Accrufer(R), Carl has willingly agreed to actively support Tim over the coming months, thereby ensuring his knowledge and expertise of Feraccru(R)/Accrufer(R) are readily available to the Company through to the closing of a partnering agreement in the United States. and in the USA the product will be marketed as Accrufer (R) with Shield currently in the process of selecting a commercialisation partner.
czar
22/4/2020
07:13
Not sure what to make of that Could be down to H2H Fiasco or lack of USA deal But from what I have seen of Carl he can certainly Present and Comes over as very confident the CFO is certainly no match in that department from the number of presentations I’ve seen. Things have undoubtedly gone on behind the scenes hopefully the consequences or not too detrimental
best1467
22/4/2020
07:10
Strange but at least staying til US deal done
deeppockets
22/4/2020
07:08
Not the RNS I was expecting. Bit confused, why would he leave now?
daveboy1
21/4/2020
18:22
Few profits being taken. Some people will have doubled their money. Good to see some interest and volume. News got to be on its way
peachie 74
21/4/2020
14:33
I'll take 5% a day at this rate!
qs99
21/4/2020
14:07
There is definitely going on, shareprice talk and this shouting something soon. Very strong in a sell off market. 270p my target.
montyhedge
21/4/2020
13:26
Very strong in this market.
montyhedge
21/4/2020
09:10
Bor is a curious character who always seems to be subtly deramping. Not sure what his game is but best ignored.
nobbygnome
21/4/2020
09:07
Looks the the rogue buyer / dumper is back today !!!
peachie 74
Chat Pages: Latest  237  236  235  234  233  232  231  230  229  228  227  226  Older
ADVFN Advertorial
Your Recent History
LSE
STX
Shield The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200710 17:31:56